肝癌筛查新指标：异常凝血酶原（PIVKA-II） - 知乎专栏
PIVKA-II 是一个首字母缩略词，表示维生素 K 缺乏（或拮抗剂）II 而诱导的蛋白质, 又称作异常凝血酶原（DCP）。 正常肝脏在维生素 K 作用下会产生凝血酶原，但是在维生素 K 缺乏或者肝 …
PIVKA-II is a useful tool for diagnostic characterization of ultrasound ...
Protein induced by vitamin K absence-II (PIVKA-II) is a potential screening marker for hepatocellular carcinoma (HCC). Limited data are available about its utility in discriminating …
Diagnostic performance of PIVKA-II in identifying recurrent ...
2024年4月10日 · Protein induced by vitamin K absence or antagonist II (PIVKA-II) plays a critical role in the diagnosis of hepatocellular carcinoma (HCC), however, studies on its efficacy in …
2022年6月17日 · pivka-ii作為維生素k缺乏的診斷的參考依據；因在正常人體內不存在pivka-ii，但在肝 病和肝惡性腫瘤病人體內，即使沒有維生素k缺乏還是會存在pivka-ii，故pivka-ii濃度 可 …
PIVKA-II serves as a potential biomarker that complements AFP …
2023年4月13日 · PIVKA-II is a promising serum biomarker for the HCC diagnosis that can be used as a supplement for AFP. The combined diagnosis of the two markers greatly improved …
肝癌肿瘤标志物AFP+PIVKA-II - 知乎 - 知乎专栏
研究结果表明，pivka-ii用于hcc早期诊断的应用优于afp，且与常规超声筛查相比，pivka-ii可提前6-12月发现hcc 。 与AFP联合筛查，提高HCC早期诊断的检出率。 本次的研究还表明，在超声 …
PIVKA-II as a Potential New Biomarker for Hepatocellular …
PIVKA-II was first described as a new biomarker in 1996 and has been used since the beginning of the 21st century. This pilot study represents the first study conducted in the Czech Republic …
PIVKA-II和AFP联合用于肝癌监测：亚太专家共识 - 健康界
2023年6月1日 · 专家们一致认为PIVKA-II在检测AFP阴性患者的HCC中有价值，并且可能有利于早期HCC联合AFP的检测。 PIVKA-II在肝细胞癌监测中的作用. 声明1：与单独使用任何生物标 …
PIVKA-II is a useful tumor marker for recurrent hepatocellular ...
Our data suggest that PIVKA-II is a useful tumor marker for HCC, complementary to AFP. Serial measurements of both markers after resection might be helpful for early diagnosis of tumor …
Elecsys ® PIVKA-II - Roche Diagnostics USA
ELECSYS PIVKA-II AND ELECSYS AFP ASSAYS DEMONSTRATE GOOD CLINICAL PERFORMANCE FOR HEPATOCELLULAR CARCINOMA (HCC) DIAGNOSIS ACROSS …